Part 4: Valuation Model for TEN IP Asset Classes | Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Feeds:: Posts; Comments

Part 4: Valuation Model for TEN IP Asset Classes

Part 4: Valuation Model for TEN IP Asset Classes

Valuation Models per Ten Digital IP Asset Classes in LPBI Group’s Portfolio of IP

Curator: Aviva Lev-Ari, PhD, RN

CHART does not include COM – Part 14 and COM – Part 15 – Will be updated in April 2026.

+ COM 15 Parts: From foundational SOPs → multimodal execution infrastructure → validation → monetization → SLM-to-LLM transition → autonomous 24/7 updating (Part 14) → Rosetta Stone Ontology & recursive discovery factories (Part 15) → MFMH.

Parts 1–10 → Part 11 → Part 12 → Part 13 →

Part 14 → Part 15 → MFMH

Composition of Methods: Tools Factory, Part 1 – 10, 11, 12, 13, 14, 15

AI BRAIN <–> COM Part 13 → Part 14 → Part 15

Multimodal Foundation Model in Healthcare

SOURCES

See, Slides for Appendices 22, 23

2026 Appendices to Every Slide N = 23 [password protected]

See, details of Portfolio of IP Assets

https://pharmaceuticalintelligence.com/2025/12/08/valuation-models-per-ten-digital-ip-asset-classes-in-lpbi-groups-portfolio-of-ip/